Deadline to submit a Case Report: Tuesday, 19 October, 2021 at 11:59 p.m. EDT
Submitted abstracts can be edited until the deadline.
Who can submit a case report?
Individuals in the early stages of their careers (whose professional training was completed five or less years ago) and trainees (including medical students) are eligible to submit case reports.
A case report must include the following information (limited to 2,140 characters, not including spaces):
- Case Report
Note: abstracts undergo a blind review process; therefore, abstain from using institution names within the case report. If accepted, you may update your presentation accordingly.
The Full Name, Affiliation, Email Address, and Disclosure Statement for the Presenting Author and each co-author must be included. There is no limit to the number of authors, and author information is not counted towards the character limit.
The Submitting Author
is responsible for notifying all named co-authors that they will be listed as a co-author on a submitted abstract.
The Presenting Author
will be the only author to receive notification of acceptance/rejection of a submitted abstract; therefore, it is the Presenting Author's responsibility to notify all co-authors regarding the outcome of an abstract submission.
You may submit a case report into only one
of the below categories. Submission of the same case report into different categories is not permitted.
Submission of one study as several different case reports is not permitted. If the case reports in question are not different enough to be considered separate studies, or if the same case report is submitted into multiple categories, all versions may be rejected.
Advanced Heart Failure and Transplantation (HEART):
Advanced Lung Failure and Transplantation (LUNG):
- HEART–Donor Related/Early Complications Post-Transplant
- HEART–Heart Failure/Cardiogenic Shock
- HEART–Infectious Diseases
- HEART–Long Term Follow-up Post Transplant
Mechanical Circulatory Support (MCS):
- LUNG–Donor/Surgical Considerations
- LUNG–Drug Induced Complications
- LUNG–Non-Covid Infectious Disease
- LUNG–Novel/Rare Indications for Transplant
Pulmonary Vascular Disease (PVD):
- MCS–Cardiac Complications
- MCS–Infectious Diseases
- MCS–Myocardial Recovery/Hemodynamics
- MCS–Pediatrics/Congenital Heart Disease
- MCS–Short Term Support
- MCS–Surgical Approaches
- PVD–Early Career Clinical Case Reports
All submitted Case Reports submitted are automatically considered for the Early Career and Trainees Clinical Case Dilemmas Best Presentation Award
. The top four case reports meeting the eligibility requirements will be selected for oral presentation
in the award session. All other accepted case reports will be selected for poster presentation
All accepted Case Reports will be published exactly as submitted
in the online version of the April 2022 Supplement of the Journal of Heart and Lung Transplantation
Visit our FAQ Page
for answers to common submission questions.